Michael J. LaBarre
2010
In 2010, Michael J. LaBarre earned a total compensation of $437.9K as Vice President, Product Development at Halozyme Therapeutics, a 21% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $63,255 |
|---|---|
| Option Awards | $118,328 |
| Salary | $248,606 |
| Other | $7,708 |
| Total | $437,897 |
LaBarre received $248.6K in salary, accounting for 57% of the total pay in 2010.
LaBarre also received $63.3K in non-equity incentive plan, $118.3K in option awards and $7.7K in other compensation.
Rankings
In 2010, Michael J. LaBarre's compensation ranked 8,142nd out of 10,439 executives tracked by ExecPay. In other words, LaBarre earned more than 22.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,142 out of 10,439 | 22nd |
Division Manufacturing | 3,028 out of 3,838 | 21st |
Major group Chemicals And Allied Products | 724 out of 921 | 21st |
Industry group Drugs | 508 out of 680 | 25th |
Industry Biological Products, Except Diagnostic Substances | 101 out of 142 | 29th |
Source: SEC filing on March 24, 2011.
LaBarre's colleagues
We found seven more compensation records of executives who worked with Michael J. LaBarre at Halozyme Therapeutics in 2010.
2010
Jonathan Lim
Halozyme Therapeutics
Chief Executive Officer
2010
Gregory Frost
Halozyme Therapeutics
Chief Executive Officer
2010
Robert Little
Halozyme Therapeutics
Vice President and Chief Commercial Officer
2010
Jonathan Leff
Halozyme Therapeutics
Chief Medical Officer
2010
William Fallon
Halozyme Therapeutics
Vice President, Manufacturing & Operations
2010
H Shepard
Halozyme Therapeutics
Chief Scientific Officer
2010
Kurt Gustafson
Halozyme Therapeutics